Pacific Biosciences of California, Inc.
(NASDAQ: PACB)

Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States. The Company's single molecule real time (SMRT) technology's combination of performance characteristics is the result of an approach that uses a single DNA polymerase working in a continuous processing manner to synthesize DNA.

1.800 -

-0.040 (-2.17%)
价格区间 1.760 - 1.920   (9.09%)
开盘 1.850
昨收 1.840
1.790
买盘 10,010
1.800
卖盘 5,581
成交量 4,631,931
成交额 5,564,934
注释 -
数据延迟。最后一次更新13 Feb 2026 01:30.
数据提供商
查看所有活动

关于 Pacific Biosciences

Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States. The Company's single molecule real time (SMRT) technology's combination of performance characteristics is the result of an approach that uses a single DNA polymerase working in a continuous processing manner to synthesize DNA.

Loading Chart...

Please login to view stock data and analysis